BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12189064)

  • 21. Adding insult to injury: reluctance to engage in clinical research with at-risk groups further disenfranchises these populations.
    Lynch HF; Dawson L
    Am J Bioeth; 2009 Nov; 9(11):62-4. PubMed ID: 19882465
    [No Abstract]   [Full Text] [Related]  

  • 22. Unnecessary holes in the head.
    Gillett GR
    IRB; 2001; 23(6):1-6. PubMed ID: 12737174
    [No Abstract]   [Full Text] [Related]  

  • 23. Is a placebo-controlled surgical trial an oxymoron?
    Boyle K; Batzer FR
    J Minim Invasive Gynecol; 2007; 14(3):278-83. PubMed ID: 17478356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When argument fails.
    Weijer C
    Am J Bioeth; 2002; 2(2):10-1. PubMed ID: 12189060
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic beneficence and patient recruitment in randomized controlled clinical trials.
    Mann H
    Am J Bioeth; 2002; 2(2):35-6. PubMed ID: 12189074
    [No Abstract]   [Full Text] [Related]  

  • 26. Randomization and the transactional framework for informed consent.
    Reynolds D; Fleming DA
    Am J Bioeth; 2009 Feb; 9(2):16-7. PubMed ID: 19180385
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical research should not be permitted to escape the ethical orbit of clinical care.
    Steinberg D
    Am J Bioeth; 2002; 2(2):27-8. PubMed ID: 12189069
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluating empirical assessments of social risk.
    Schonfeld T; Brown JS
    Am J Bioeth; 2009 Nov; 9(11):55-6. PubMed ID: 19882461
    [No Abstract]   [Full Text] [Related]  

  • 29. Effective trial design need not conflict with good patient care.
    Glass KC; Waring D
    Am J Bioeth; 2002; 2(2):25-6. PubMed ID: 12189068
    [No Abstract]   [Full Text] [Related]  

  • 30. Research participation and financial inducements.
    Resnik DB
    Am J Bioeth; 2001; 1(2):54-6. PubMed ID: 11951894
    [No Abstract]   [Full Text] [Related]  

  • 31. The need to explicate the ethical evaluation tools to avoid ethical inflation.
    Bernabe RD; van Thiel GJ; Raaijmakers JA; van Delden JJ
    Am J Bioeth; 2009 Nov; 9(11):56-8. PubMed ID: 19882462
    [No Abstract]   [Full Text] [Related]  

  • 32. The ethics of clinical research in developing countries.
    Brunet-Jailly J
    IRB; 1999; 21(5):8-11. PubMed ID: 12625349
    [No Abstract]   [Full Text] [Related]  

  • 33. Equipoise may be in the eye of the beholder.
    Moyer A; Floyd AH
    Am J Bioeth; 2009 Feb; 9(2):21-2. PubMed ID: 19180388
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomization can be risky.
    Lott J
    Am J Bioeth; 2009 Feb; 9(2):17-8. PubMed ID: 19180386
    [No Abstract]   [Full Text] [Related]  

  • 35. Understanding randomization: helpful strategies.
    Brody H; Childress AM
    Am J Bioeth; 2009 Feb; 9(2):14-5. PubMed ID: 19180384
    [No Abstract]   [Full Text] [Related]  

  • 36. The design and use of cluster randomised controlled trials in evaluating injury prevention interventions: part 1. Rationale, design and informed consent.
    DiGuiseppi C; Coupland C
    Inj Prev; 2010 Feb; 16(1):61-7. PubMed ID: 20179039
    [No Abstract]   [Full Text] [Related]  

  • 37. Equipoise trumps randomization.
    Fox MD; Hellman CM; Jelley MR
    Am J Bioeth; 2009 Feb; 9(2):13-4. PubMed ID: 19180383
    [No Abstract]   [Full Text] [Related]  

  • 38. To study, perchance to treat.
    Trachtman H
    Am J Bioeth; 2009 Feb; 9(2):11-2. PubMed ID: 19180382
    [No Abstract]   [Full Text] [Related]  

  • 39. A step toward truly protecting human subjects: reviewing the review boards.
    Albrecht RR
    Am J Bioeth; 2004; 4(1):54-5. PubMed ID: 15035952
    [No Abstract]   [Full Text] [Related]  

  • 40. The dirty little truth: we want them to understand, but not really..
    Morreim H
    Am J Bioeth; 2009 Feb; 9(2):9-11. PubMed ID: 19180381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.